CRISPRB LTD

Company number 15875016 · Active

CRISPRB LTD is a private limited company registered in LONDON, United Kingdom, incorporated on 3 Aug 2024. Its registered activity is other human health activities. Its latest published accounts for the period ending 31 Aug 2025 show equity of £12k, total assets of £77k. It has filed 1 set of accounts.

Company details

Company number
15875016 · official register
Status
Active
Legal form
Private Limited Company
Incorporated
3 Aug 2024 (2 years)
Registered address
WC2A 1HR LONDON
Postcode area
London West Central
Activity
86900 Other human health activities
Industry
Human health activities
Accounts overdue
No

Insolvency and register events

No insolvency or liquidation events on record.

Annual accounts GBP

Period endPublishedTurnoverResultEquityTotal assetsCurrent liabilitiesCashEmployees
31 Aug 202515 Mar 2026– –£12k£77k £65k£35k1

As published. Small companies often file a balance sheet only, so turnover and result can be missing.

Similar companies in London West Central

Questions about CRISPRB LTD

What is the company number of CRISPRB LTD?

CRISPRB LTD is registered under company number 15875016 in the official register of United Kingdom. View it at the official register.

Is CRISPRB LTD still active?

Yes. CRISPRB LTD is registered as active (status: Active).

Has CRISPRB LTD gone bankrupt or into insolvency?

No insolvency, bankruptcy or administration is recorded for CRISPRB LTD in the official data.

When was CRISPRB LTD founded?

CRISPRB LTD was incorporated on 3 Aug 2024.

Where is CRISPRB LTD registered?

CRISPRB LTD's registered address is in WC2A 1HR LONDON (London West Central), United Kingdom.

What do the latest accounts of CRISPRB LTD show?

The latest published accounts (period ending 31 Aug 2025) show equity of £12k, total assets of £77k, 1 employees.

Data: Companies House – Free Company Data Product, Accounts Data Product, Public Data API (Contains public sector information licensed under the Open Government Licence v3.0.). Last updated 7 Nov 2026.